NL300012I2 - Vasotocinederivaten. - Google Patents

Vasotocinederivaten.

Info

Publication number
NL300012I2
NL300012I2 NL300012C NL300012C NL300012I2 NL 300012 I2 NL300012 I2 NL 300012I2 NL 300012 C NL300012 C NL 300012C NL 300012 C NL300012 C NL 300012C NL 300012 I2 NL300012 I2 NL 300012I2
Authority
NL
Netherlands
Prior art keywords
peptide residue
sub
derivatives
vasotocin
residue
Prior art date
Application number
NL300012C
Other languages
English (en)
Other versions
NL300012I1 (nl
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8207277A external-priority patent/SE8207277L/xx
Application filed by Ferring Ab filed Critical Ferring Ab
Publication of NL300012I1 publication Critical patent/NL300012I1/nl
Publication of NL300012I2 publication Critical patent/NL300012I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL300012C 1982-12-21 2000-07-13 Vasotocinederivaten. NL300012I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8207277A SE8207277L (sv) 1982-12-21 1982-12-21 Vasotocin-derivat
SE8302505A SE8302505L (sv) 1982-12-21 1983-05-03 Vasotocin-derivat

Publications (2)

Publication Number Publication Date
NL300012I1 NL300012I1 (nl) 2000-10-02
NL300012I2 true NL300012I2 (nl) 2001-02-01

Family

ID=26658329

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300012C NL300012I2 (nl) 1982-12-21 2000-07-13 Vasotocinederivaten.

Country Status (12)

Country Link
US (1) US4504469A (nl)
EP (1) EP0112809B1 (nl)
AT (1) ATE20072T1 (nl)
AU (1) AU564255B2 (nl)
CA (1) CA1216843A (nl)
DE (2) DE10075020I2 (nl)
DK (1) DK163186C (nl)
ES (1) ES8607990A1 (nl)
FI (1) FI78305C (nl)
IL (1) IL70498A (nl)
NL (1) NL300012I2 (nl)
NO (1) NO160144C (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599324A (en) * 1984-11-21 1986-07-08 Smithkline Beckman Corporation V1-vasopressin antagonists
US4711877A (en) * 1985-09-18 1987-12-08 Smithkline Beckman Corporation 6-pen-vasopressin compounds
FR2597483B1 (fr) * 1986-04-18 1993-09-10 Flork Michel Nouveaux peptides diuretiques et natriuretiques.
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
AT398766B (de) * 1988-05-26 1995-01-25 Gebro Broschek Gmbh Verfahren zur intramolekularen oxidation von zwei -sh gruppen in einer peptidverbindung zu einer disulfidbrücke
CA2014590C (en) * 1989-04-15 1999-12-14 Mitsuo Masaki Novel peptides, and antidementia agents containing the same
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists
SE9002384D0 (sv) * 1990-07-09 1990-07-09 Ferring Ab Derivat av baklobshormoner
US20040152170A1 (en) * 2001-12-14 2004-08-05 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
JP2005512538A (ja) * 2001-12-14 2005-05-12 セントカー・インコーポレーテツド 無血清培地中でタンパク質を製造するのに有用なクローン性骨髄腫細胞系
US20030166147A1 (en) * 2001-12-14 2003-09-04 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
EP1555029A1 (en) 2004-01-19 2005-07-20 Ferring B.V. Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
US8030446B2 (en) * 2006-02-10 2011-10-04 Trustees Of Dartmouth College Mutant proline-and-arginine rich peptides and methods for using the same
CN101357937B (zh) * 2007-07-31 2012-11-07 上海苏豪逸明制药有限公司 固相多肽合成阿托西般的制备方法
CN102127146B (zh) 2010-12-24 2013-04-24 深圳翰宇药业股份有限公司 一种制备醋酸阿托西班的方法
CN102584953B (zh) * 2012-02-09 2014-01-01 深圳翰宇药业股份有限公司 一种阿托西班的纯化方法
AU2017205670B2 (en) 2016-01-04 2021-05-20 Merck Serono S.A. L-valinate of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
CA3031252A1 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
EP4025207A1 (en) 2019-09-03 2022-07-13 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
US20230102503A1 (en) 2020-02-10 2023-03-30 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
WO2022101495A1 (en) 2020-11-16 2022-05-19 ObsEva S.A. Compositions and methods for the treatment or prevention of preterm labor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051686A (nl) * 1963-04-05
NL129421C (nl) * 1963-08-30 1900-01-01
CH442342A (de) * 1964-07-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
ZA733419B (en) * 1972-07-04 1974-03-27 Hoffmann La Roche Nonapeptides and process for the preparation thereof
US4081533A (en) * 1976-09-01 1978-03-28 Regents Of The University Of California Method of reducing mammalian fertility and drugs therefor
US4163011A (en) * 1978-08-28 1979-07-31 Orts Richard J Peptide compounds and compositions
SE430885B (sv) * 1980-03-24 1983-12-19 Ferring Ab Oxytocin-derivat
US4367225A (en) * 1981-03-24 1983-01-04 The Medical College Of Ohio Novel antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin

Also Published As

Publication number Publication date
US4504469A (en) 1985-03-12
DK586783D0 (da) 1983-12-20
IL70498A0 (en) 1984-03-30
ES8607990A1 (es) 1986-06-01
AU564255B2 (en) 1987-08-06
DE10075020I2 (de) 2003-01-09
FI834634A (fi) 1984-06-22
IL70498A (en) 1987-09-16
NL300012I1 (nl) 2000-10-02
DK163186B (da) 1992-02-03
FI78305B (fi) 1989-03-31
ATE20072T1 (de) 1986-06-15
NO160144B (no) 1988-12-05
AU2257783A (en) 1984-06-28
CA1216843A (en) 1987-01-20
DE3363830D1 (en) 1986-07-03
FI78305C (fi) 1989-07-10
DE10075020I1 (de) 2000-09-21
NO160144C (no) 1989-03-15
FI834634A0 (fi) 1983-12-16
DK586783A (da) 1984-06-22
ES528211A0 (es) 1986-06-01
DK163186C (da) 1992-06-22
EP0112809A1 (en) 1984-07-04
EP0112809B1 (en) 1986-05-28
NO834691L (no) 1984-06-22

Similar Documents

Publication Publication Date Title
DE3363830D1 (en) Vasotocin derivatives
US4005063A (en) [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
US4565804A (en) GnRH Antagonists VI
US4689396A (en) GnRH antagonists V
PH18967A (en) Peptides and pharmaceutical composition thereof
CA2014590A1 (en) Novel peptides, and antidementia agents containing the same
Sievertsson et al. Hypothalamic hormones. 35. Two syntheses of the luteinizing hormone releasing hormone of the hypothalamus
ATE42308T1 (de) Pharmakologisch aktive peptide.
GB1526367A (en) Polypeptide
EP0038135A2 (en) LRF antagonists
IE58287B1 (en) Spiro-heteroazolones for treatment of diabetes complications
DK74780A (da) Psyko-farmakologiske peptider
JPS5283545A (en) Tri-and tetrapeptides and their derivatives
KITAGAWA et al. Alternative Synthesis of Substance P
GB1155925A (en) Synthesis Of Octapeptides
JPS57145846A (en) Preparation of tripeptide and its derivative
ES8501365A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
北川幸己 et al. Alternative synthesis of substance P.